Status:
COMPLETED
Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic
Lead Sponsor:
University of Utah
Conditions:
Oncology
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This project will evaluate the benefit of an automated home symptom monitoring system, Symptom Care at Home, to track COVID-19 symptoms, provide instructions to reduce COVID-19 exposure, and reduce ca...
Detailed Description
In response to the COVID-19 pandemic, there is an opportunity to rapidly flex platforms for remote cancer symptom tracking and management to incorporate COVID-19 symptom monitoring and reinforce risk-...
Eligibility Criteria
Inclusion
- Participants will be patients who are receiving treatment for a cancer diagnosis at Huntsman Cancer Hospital.
- Must be able to speak, read, and understand English language.
- Must have a smartphone and be willing and able to download the SCH application and enter data into the application OR must be willing to make phone calls to report symptoms using the telephone interactive voice response (IVR) system.
Exclusion
- Patients enrolled in another study protocol that prohibits participation in other trials.
- Patients under the age of 18.
Key Trial Info
Start Date :
April 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT04464486
Start Date
April 21 2020
End Date
September 30 2022
Last Update
November 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huntsman Cancer Institute
Salt Lake City, Utah, United States, 84132